Found 14 matching trials
A Study of TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy PHASE3 The purpose of this study is to evaluate the efficacy and safety of TMC435 ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus PHASE2 The purpose of this study is to explore the efficacy and safety of TMC64705...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study PHASE2 A study to evaluate the safety and effect of treatment with experimental an...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy PHASE3 The purpose of this study is to investigate the effectiveness and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants PHASE3 The purpose of this study is to investigate the effectiveness and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial
Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir Therapy N/A This is a multicenter, prospective cohort study to evaluate the efficacy an...
Show More Location
The First Affiliated Hospital, Anhui Medical University
Learn More & Join Trial
Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C PHASE4 Response-guided triple-therapy with boceprevir (BOC) in combination with pe...
Show More Location
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna
Learn More & Join Trial
A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment PHASE2 Debio 025 (alisporivir) is an oral cyclophilin inhibitor with a new mechani...
Show More Location
Scripps Clinic Liver Disease Research Center
Learn More & Join Trial
Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects PHASE2 The purpose of this study was to assess the safety, pharmacokinetics, and 4...
Show More Location
Site Reference ID/Investigator# 56623
Learn More & Join Trial
Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B PHASE4 The purpose of this study is to investigate whether it is possible to augme...
Show More Learn More & Join Trial